Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Assess which market exposure—Total Market or SP 500—offers more durable performance for retirement spending and resilience.
28,477 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
The June jobs report shows tepid hiring even as unemployment falls, highlighting mixed signals for households and mar...
Bitcoin dropped about $2,000 in minutes after a prominent political figure signaled unwavering support for crypto, tr...
The new FED chief presides over his first policy meeting, keeping rates steady while outlining a cautious, data-drive...
Lam Research has quietly outpaced rivals in AI tooling, delivering triple-digit gains as 2026 guidance stays upbeat. ...
An executive stock sale can signal many things. This article breaks down the numbers, the reporting rules, and practi...
BNB Chain completes 36th quarterly burn, marking the third burn of 2026. The auto-burn removed 1.615 million BNB, bri...
A Wimbledon moment with prince george princess charlotte offers more than bragging rights. It’s a concrete reminder: ...
A major fund just boosted its stake in a struggling auto-parts retailer. This article breaks down what the move could...
Geopolitical moves from the July U.S. strike on Iran sent shockwaves through crypto markets as Bitcoin and Ethereum p...
This week, strategy (formerly microstrategy) stock dropped sharply as Bitcoin volatility clashed with treasury moves....
Snow-season demand shapes profitability for snow equipment makers. This article breaks down douglas dynamics (plow) e...